• @[email protected]
    link
    fedilink
    English
    -461 year ago

    Personalized medicine is a way to rob you blind. Drugs cost unreal money. So does the hospital administration.

      • @[email protected]
        link
        fedilink
        English
        101 year ago

        I worked for one the first hospitals that was doing genomic testing for oncology patients in the U.S. I am not advocating against genomic testing or precision medicine, but Amerisource Bergen, (at the time) McKesson, and the sales people at the manufacturer were licking their chops at the thought of precision medicine. It was extremely lucrative for some improvements on QoL. I sincerely hope that it’s not cost prohibitive to patients and results in breakthroughs in treatment. But I did watch as a lung cancer drug was administered to patients at the cost of 250k per treatment. I don’t remember how many treatments there were but the cost was insane. The US system of healthcare is absolutely broken and I believe there’s a study that particularly evaluated cancer as a major cause of families depleting whatever savings they had within a couple years of being diagnosed. This is an indictment of the whole system. Not the efficacy of the drugs.

    • Ghostalmedia
      link
      fedilink
      English
      221 year ago

      But isn’t personalized treatment kind of key to treating cancer?

      • @[email protected]
        link
        fedilink
        English
        211 year ago

        Most modern cancer drug treatment is sequenced to at least the specific proteins of the type of cancer it is.

        Have breast cancer? Cool. We figure out which of the many variations so that we can give you medications for that exact type of breast cancer.

        This sort of specific targeting has been increasing and increasing for the last 20 years. MRNA is the next step of that and is highly likely to be a means or become or for treatments in many other areas.